Abstract
In December 2019, a novel coronavirus COVID-19 emerged from Wuhan, China, and was soon declared as pandemic by the World Health Organization (WHO) on the 11 March 2020.1 The UK soon followed suit and implemented a national lockdown on the 23 March 2020. As of 9 December 2020, according to WHO, this highly infectious virus has infected more than 67 million people and led to over 1.5 million deaths across the world.2 There is a growing body of evidence on the epidemiology of the condition, risk factors for poor outcomes and effects of interventions.3–9
Original language | English |
---|---|
Pages (from-to) | 1064-1074 |
Number of pages | 11 |
Journal | International Journal of Epidemiology |
Volume | 50 |
Issue number | 4 |
Early online date | 5 Jun 2021 |
DOIs | |
Publication status | Published - Aug 2021 |
Bibliographical note
The original EAVE project was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 13/34/14). EAVE II is funded by the Medical Research Council [MR/R008345/1] and supported by the Scottish Government. This work is supported by BREATHE—The Health Data Research Hub for Respiratory Health [MC_PC_19004]. BREATHE is funded through 10 the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK.Keywords
- Scotland
- surveillance
- medical
- pandemics
- covid-19